Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Depression

  Free Subscription


Articles published in Neurology

Retrieve available abstracts of 68 articles:
HTML format



Single Articles


    May 2021
  1. SAFT C, Skodda S, Nguyen HP, Park J, et al
    Teaching Video NeuroImages: New STUB1 Variant Causes Chorea, Tremor, Dystonia, Myoclonus, Ataxia, Depression, Cognitive Impairment, Epilepsy, and Superficial Siderosis.
    Neurology. 2021 May 26. pii: WNL.0000000000012264.
    PubMed    


    April 2021
  2. LEAVITT VM, Dobson R, Svennigsson A
    Perinatal Depression and Anxiety in Multiple Sclerosis: Treatable Distress.
    Neurology. 2021 Apr 28. pii: WNL.0000000000012101.
    PubMed    


  3. EID K, Torkildsen OF, Aarseth J, Flemmen HO, et al
    Perinatal Depression and Anxiety in Women with Multiple Sclerosis: A Population-Based Cohort Study.
    Neurology. 2021 Apr 21. pii: WNL.0000000000012062.
    PubMed     Abstract available


    March 2021
  4. MAYMAN N, Stein LK, Erdman J, Kornspun A, et al
    Risk and Predictors of Depression Following Acute Ischemic Stroke in the Elderly.
    Neurology. 2021 Mar 15. pii: WNL.0000000000011828.
    PubMed     Abstract available


    February 2021
  5. WILLIAMS OA, Demeyere N
    Association of Depression and Anxiety With Cognitive Impairment 6 Months After Stroke.
    Neurology. 2021 Feb 25. pii: WNL.0000000000011748.
    PubMed     Abstract available


    December 2020
  6. ADANK MC, Hussainali RF, Oosterveer LC, Ikram MA, et al
    Hypertensive disorders of pregnancy and cognitive impairment: A prospective cohort study.
    Neurology. 2020 Dec 30. pii: WNL.0000000000011363.
    PubMed     Abstract available


  7. BINZER S, Manouchehrinia A, Hillert J
    Author response: Disability worsening among persons with multiple sclerosis and depression: A Swedish cohort study.
    Neurology. 2020;95:1026.
    PubMed    


  8. BSTEH G, Berger T
    Reader response: Disability worsening among persons with multiple sclerosis and depression: A Swedish cohort study.
    Neurology. 2020;95:1025-1026.
    PubMed    


  9. GANESH A, Galetta S
    Editors' note: Disability worsening among persons with multiple sclerosis and depression: A Swedish cohort study.
    Neurology. 2020;95:1025.
    PubMed    


    November 2020
  10. MCMURRY HS, Tsang DC, Lin N, Symes SN, et al
    Head injury and neuropsychiatric sequelae in asylum seekers.
    Neurology. 2020;95:e2605-e2609.
    PubMed     Abstract available


    October 2020
  11. FRIEDMAN JH, Goetz CG
    Apathy in Parkinson's disease: Why we should care.
    Neurology. 2020 Oct 1. pii: WNL.0000000000010961.
    PubMed    


  12. SCOTT BM, Eisinger RS, Burns MR, Lopes J, et al
    Co-occurrence of apathy and impulse control disorders in Parkinson's disease.
    Neurology. 2020 Oct 1. pii: WNL.0000000000010965.
    PubMed     Abstract available


    September 2020
  13. BARATEAU L, Lopez R, Chenini S, Pesenti C, et al
    Depression and suicidal thoughts in untreated and treated narcolepsy: Systematic analysis.
    Neurology. 2020 Sep 22. pii: WNL.0000000000010737.
    PubMed     Abstract available


    August 2020
  14. HUANG J, Zuber V, Matthews PM, Elliott P, et al
    Sleep, major depressive disorder and Alzheimer's disease: A Mendelian randomisation study.
    Neurology. 2020 Aug 19. pii: WNL.0000000000010463.
    PubMed     Abstract available


  15. NIGHTSCALES R, McCartney L, Auvrez C, Tao G, et al
    Mortality in patients with psychogenic nonepileptic seizures.
    Neurology. 2020;95:e643-e652.
    PubMed     Abstract available


  16. DOUROS A, Boivin JF, Renoux C
    Author response: Degree of serotonin reuptake inhibition of antidepressants and ischemic risk: A cohort study.
    Neurology. 2020;95:232.
    PubMed    


  17. KAWADA T
    Reader response: Degree of serotonin reuptake inhibition of antidepressants and ischemic risk: A cohort study.
    Neurology. 2020;95:231-232.
    PubMed    


  18. SALTER A, Kowalec K, Fitzgerald KC, Cutter G, et al
    Comorbidity is associated with disease activity in MS: Findings from the CombiRx trial.
    Neurology. 2020;95:e446-e456.
    PubMed     Abstract available


    July 2020
  19. NAIR DR, Laxer KD, Weber PB, Murro AM, et al
    Nine-year prospective efficacy and safety of brain-responsive neurostimulation for focal epilepsy.
    Neurology. 2020 Jul 20. pii: WNL.0000000000010154.
    PubMed     Abstract available


    June 2020
  20. ALOSCO ML, Tripodis Y, Baucom ZH, Mez J, et al
    The Late Contributions of Repetitive Head Impacts and TBI to Depression Symptoms and Cognition.
    Neurology. 2020 Jun 26. pii: WNL.0000000000010040.
    PubMed     Abstract available


  21. GUEDES VA, Kenney K, Shahim P, Qu BX, et al
    Exosomal neurofilament light: A prognostic biomarker for remote symptoms after mild traumatic brain injury?
    Neurology. 2020;94:e2412-e2423.
    PubMed     Abstract available


    April 2020
  22. DONG L, Sanchez BN, Skolarus LE, Stulberg E, et al
    Sex difference in prevalence of depression after stroke.
    Neurology. 2020 Apr 20. pii: WNL.0000000000009394.
    PubMed     Abstract available


  23. PONTONE GM, Mills KA
    A call for better depression treatment in people with Parkinson disease.
    Neurology. 2020 Apr 1. pii: WNL.0000000000009285.
    PubMed    


  24. DOBKIN RD, Mann SL, Gara MA, Interian A, et al
    Telephone-based cognitive behavioral therapy for depression in Parkinson disease: A randomized controlled trial.
    Neurology. 2020 Apr 1. pii: WNL.0000000000009292.
    PubMed     Abstract available


    March 2020
  25. FOSTER E, Malpas CB, Ye K, Johnstone B, et al
    Antiepileptic drugs are not independently associated with cognitive dysfunction.
    Neurology. 2020;94:e1051-e1061.
    PubMed     Abstract available


    December 2019
  26. APPLETON JP, Woodhouse LJ, Adami A, Becker JL, et al
    Imaging markers of small vessel disease and brain frailty, and outcomes in acute stroke.
    Neurology. 2019 Dec 27. pii: WNL.0000000000008881.
    PubMed     Abstract available


  27. MARRIE RA, Whitehouse C, Fisk J
    Author response: Comorbid anxiety, depression, and cognition in MS and other immune-mediated disorders.
    Neurology. 2019;93:1081-1082.
    PubMed    


  28. GOLAN D
    Reader response: Comorbid anxiety, depression, and cognition in MS and other immune-mediated disorders.
    Neurology. 2019;93:1080-1081.
    PubMed    


  29. SIEGLER JE 3RD, Galetta S
    Editors' note: Comorbid anxiety, depression, and cognition in MS and other immune-mediated disorders.
    Neurology. 2019;93:1080.
    PubMed    


    November 2019
  30. BINZER S, McKay KA, Brenner P, Hillert J, et al
    Disability worsening among persons with multiple sclerosis and depression: A Swedish cohort study.
    Neurology. 2019 Nov 8. pii: WNL.0000000000008617.
    PubMed     Abstract available


  31. ESPAY AJ, Ries S, Maloney T, Vannest J, et al
    Clinical and neural responses to cognitive behavioral therapy for functional tremor.
    Neurology. 2019;93:e1787-e1798.
    PubMed     Abstract available


    September 2019
  32. BUNEVICIUS A
    Reader response: Depressed TSH level as a predictor of poststroke fatigue in patients with acute ischemic stroke.
    Neurology. 2019;93:563-564.
    PubMed    


    July 2019
  33. DEMARTINI B, Gambini O, Uggetti C, Cariati M, et al
    Limbic neurochemical changes in patients with functional motor symptoms.
    Neurology. 2019;93:e52-e58.
    PubMed     Abstract available


    April 2019
  34. MCGARRY A, McDermott MP, Kieburtz K, Fung WLA, et al
    Risk factors for suicidality in Huntington disease: An analysis of the 2CARE clinical trial.
    Neurology. 2019;92:e1643-e1651.
    PubMed     Abstract available


    March 2019
  35. BURSCH B, Mulligan C, Keener AM, Aralis H, et al
    Education Research: Evaluation of curriculum to teach resilience skills to neurology residents.
    Neurology. 2019;92:538-541.
    PubMed     Abstract available


  36. TAY J, Tuladhar AM, Hollocks MJ, Brookes RL, et al
    Apathy is associated with large-scale white matter network disruption in small vessel disease.
    Neurology. 2019;92:e1157-e1167.
    PubMed     Abstract available


    February 2019
  37. SCHULTZ JL, Killoran A, Nopoulos PC, Moser DJ, et al
    Author response: Evaluating depression and suicidality in tetrabenazine users with Huntington disease.
    Neurology. 2019;92:448.
    PubMed    


  38. SAMPAIO C, Ware JJ, Macleod M, Wagenmakers EJ, et al
    Reader response: Evaluating depression and suicidality in tetrabenazine users with Huntington disease.
    Neurology. 2019;92:447-448.
    PubMed    


  39. SCHULTZ JL
    Author response: Evaluating depression and suicidality in tetrabenazine users with Huntington disease.
    Neurology. 2019;92:447.
    PubMed    


  40. AZIZ NA
    Reader response: Evaluating depression and suicidality in tetrabenazine users with Huntington disease.
    Neurology. 2019;92:446-447.
    PubMed    


  41. SIEGLER JE 3RD, Galetta S
    Editors' note: Evaluating depression and suicidality in tetrabenazine users with Huntington disease.
    Neurology. 2019;92:446.
    PubMed    


  42. RUTTEN S, Vriend C, Smit JH, Berendse HW, et al
    Bright light therapy for depression in Parkinson disease: A randomized controlled trial.
    Neurology. 2019 Feb 15. pii: WNL.0000000000007090.
    PubMed     Abstract available


  43. VIDENOVIC A, Messinis L
    Enlightened PD: A novel treatment for Parkinson disease?
    Neurology. 2019 Feb 15. pii: WNL.0000000000007078.
    PubMed    


    January 2019
  44. YAFFE K, Lwi SJ, Hoang TD, Xia F, et al
    Military-related risk factors in female veterans and risk of dementia.
    Neurology. 2019;92:e205-e211.
    PubMed     Abstract available


  45. FEINSTEIN A, Brochet B, Sumowski J
    The cognitive effects of anxiety and depression in immune-mediated inflammatory diseases.
    Neurology. 2019 Jan 11. pii: WNL.0000000000006840.
    PubMed    


  46. WHITEHOUSE CE, Fisk JD, Bernstein CN, Berrigan LI, et al
    Comorbid anxiety, depression, and cognition in MS and other immune-mediated disorders.
    Neurology. 2019 Jan 11. pii: WNL.0000000000006854.
    PubMed     Abstract available


  47. RAYNER G, Tailby C, Jackson G, Wilson S, et al
    Looking beyond lesions for causes of neuropsychological impairment in epilepsy.
    Neurology. 2019 Jan 11. pii: WNL.0000000000006905.
    PubMed     Abstract available


    December 2018
  48. SCHNEIDER ALC, Ling G
    Associations of TBI, PTSD, and depression with dementia risk among female military veterans: Not just men.
    Neurology. 2018 Dec 12. pii: WNL.0000000000006768.
    PubMed    


    June 2018
  49. SCHULTZ JL, Killoran A, Nopoulos PC, Chabal CC, et al
    Evaluating depression and suicidality in tetrabenazine users with Huntington disease.
    Neurology. 2018 Jun 20. pii: WNL.0000000000005817.
    PubMed     Abstract available


    April 2018
  50. KOO BB, Chow CA, Shah DR, Khan FH, et al
    Demoralization in Parkinson disease.
    Neurology. 2018 Apr 4. pii: WNL.0000000000005425.
    PubMed     Abstract available


    March 2018
  51. FRATTINI E, Monfrini E, Bitetto G, Ferrari B, et al
    Clinical Reasoning: A 75-year-old man with parkinsonism, mood depression, and weight loss.
    Neurology. 2018;90:572-575.
    PubMed    


    December 2017
  52. FITZGERALD KC, Tyry T, Salter A, Cofield SS, et al
    Diet quality is associated with disability and symptom severity in multiple sclerosis.
    Neurology. 2017 Dec 6. pii: WNL.0000000000004768.
    PubMed     Abstract available


    November 2017
  53. KOWALEC K, McKay KA, Patten SB, Fisk JD, et al
    Comorbidity increases the risk of relapse in multiple sclerosis: A prospective study.
    Neurology. 2017 Nov 8. pii: 10.1212/WNL.0000000000004716.
    PubMed     Abstract available


    October 2017
  54. DE KONING ME, Scheenen ME, van der Horn HJ, Timmerman ME, et al
    Prediction of work resumption and sustainability up to 1 year after mild traumatic brain injury.
    Neurology. 2017;89:1908-1914.
    PubMed     Abstract available


  55. UC EY, Rizzo M, O'Shea AMJ, Anderson SW, et al
    Longitudinal decline of driving safety in Parkinson disease.
    Neurology. 2017 Oct 11. pii: 10.1212/WNL.0000000000004629.
    PubMed     Abstract available


    August 2017
  56. ROSSI S, Studer V, Motta C, Polidoro S, et al
    Neuroinflammation drives anxiety and depression in relapsing-remitting multiple sclerosis.
    Neurology. 2017 Aug 25. pii: 10.1212/WNL.0000000000004411.
    PubMed     Abstract available


    July 2017
  57. SAYLOR D, Nakigozi G, Nakasujja N, Robertson K, et al
    Peripheral neuropathy in HIV-infected and uninfected patients in Rakai, Uganda.
    Neurology. 2017 Jul 5. pii: 10.1212/WNL.0000000000004136.
    PubMed     Abstract available


    June 2017
  58. DE JONG HJI, Kingwell E, Shirani A, Cohen Tervaert JW, et al
    Evaluating the safety of beta-interferons in MS: A series of nested case-control studies.
    Neurology. 2017;88:2310-2320.
    PubMed     Abstract available


    May 2017
  59. OLAIYA MT, Cadilhac DA, Kim J, Nelson MR, et al
    Long-term unmet needs and associated factors in stroke or TIA survivors: An observational study.
    Neurology. 2017 May 31. pii: 10.1212/WNL.0000000000004063.
    PubMed     Abstract available


    March 2017
  60. KSENDZOVSKY A, Pomeraniec IJ, Zaghloul KA, Provencio JJ, et al
    Clinical implications of the melanopsin-based non-image-forming visual system.
    Neurology. 2017;88:1282-1290.
    PubMed     Abstract available


  61. MARRIE RA, Salter A, Tyry T, Cutter GR, et al
    High hypothetical interest in physician-assisted death in multiple sclerosis.
    Neurology. 2017 Mar 15. pii: 10.1212/WNL.0000000000003831.
    PubMed     Abstract available


    December 2016
  62. THOLFSEN LK, Larsen JP, Schulz J, Tysnes OB, et al
    Changes in insomnia subtypes in early Parkinson disease.
    Neurology. 2016 Dec 16. pii: 10.1212/WNL.0000000000003540.
    PubMed     Abstract available


    November 2016
  63. CRAGG JJ, Seals R, Cashman N, Weisskopf MG, et al
    Journal Club: Depression before and after diagnosis with amyotrophic lateral sclerosis.
    Neurology. 2016;87:e257-e259.
    PubMed    


  64. LOUTER MA, Pelzer N, de Boer I, Kuijvenhoven BE, et al
    Prevalence of lifetime depression in a large hemiplegic migraine cohort.
    Neurology. 2016 Nov 2. pii: 10.1212/WNL.0000000000003376.
    PubMed     Abstract available


    October 2016
  65. KAWADA T, Thakore NJ, Pioro EP
    Depression in ALS in a large self-reporting cohort.
    Neurology. 2016;87:1631-1632.
    PubMed    


    September 2016
  66. LOUTER MA, Wilbrink LA, Haan J, van Zwet EW, et al
    Cluster headache and depression.
    Neurology. 2016 Sep 30. pii: 10.1212/WNL.0000000000003282.
    PubMed     Abstract available


    May 2016
  67. NELSON LD, Tarima S, LaRoche AA, Hammeke TA, et al
    Preinjury somatization symptoms contribute to clinical recovery after sport-related concussion.
    Neurology. 2016;86:1856-63.
    PubMed     Abstract available


  68. VAN DER HEEDEN JF, Marinus J, Martinez-Martin P, Rodriguez-Blazquez C, et al
    Postural instability and gait are associated with severity and prognosis of Parkinson disease.
    Neurology. 2016 May 13. pii: 10.1212/WNL.0000000000002768.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Depression is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: